IL6 and gastric cancer: GC patient serum-derived IL-6 and IL-8 activates the PI3 kinase signaling pathway in CD45+CD33lowCD11bdim MDSCs to induce arginase I production and release, thereby inhibiting the activity of CD8+ T cells.